Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ACTV8PRO
- Development stage
- Unknown
- Lead developer
- C. Contrad Swiss
- Modality
- Peptides
- Administration
- Topical
01
Overview
ACTV8PRO is a professional-grade regenerative aesthetics product line developed by Contrad Swiss SA. The line is powered by proprietary SIGMOLECS® Technology, which integrates customized biomimetic peptide sequences with hyaluronic acid. These products are specifically designed for in-clinic use by aesthetic physicians to support and accelerate the recovery process following procedures such as laser treatments, microneedling, chemical peels, and radiofrequency therapy. By promoting wound healing, skin regeneration, and collagenogenesis, ACTV8PRO aims to minimize downtime and enhance the clinical outcomes of aesthetic interventions. The product range includes specialized formulations such as an Epidermal Recovery Agent, a Periocular Formula, and a Labial Post-Filler treatment.
- Brand names
- ACTV8PROACTV-8PROACTV 8PRO
- Other names
- ACTV8PRO Regenerative AestheticsACTV-8PRO Regenerative AestheticsACTV 8PRO Regenerative Aesthetics
Beyond the preview
Go deeper on ACTV8PRO.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ACTV8PRO.